Quinidine Gluconate for Horses: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Quinidine gluconate is a prescription antiarrhythmic medication used in horses to help control abnormal heart rhythms. It belongs to the Class IA antiarrhythmic group, which works by slowing electrical conduction through the heart and changing how heart muscle cells recover between beats.

In equine medicine, quinidine is best known for its role in treating atrial fibrillation (AF), a rhythm problem where the atria beat in a disorganized way. Horses with AF may have poor performance, exercise intolerance, or an irregularly irregular heartbeat. Some horses show few signs at rest, which is why diagnosis and treatment planning usually depend on an exam, ECG, and echocardiography performed by your vet.

Quinidine comes in different salt forms, including quinidine sulfate and quinidine gluconate. In horses, oral quinidine sulfate has historically been the main drug used for medical cardioversion, while quinidine gluconate is used intravenously in carefully monitored hospital settings. Because this drug can affect blood pressure, conduction through the heart, and the risk of other arrhythmias, it should only be given under direct veterinary supervision.

In horses, quinidine is used primarily to help convert atrial fibrillation back to normal sinus rhythm. This is most often considered in athletic horses, horses with reduced exercise tolerance, or horses whose rhythm problem is expected to limit safety or performance. Your vet may recommend medical cardioversion with quinidine, electrical cardioversion, or another plan depending on how long the AF has been present and whether there is underlying heart disease.

Quinidine treatment is usually most successful in horses with recent-onset AF and little to no structural heart disease. Horses with marked atrial enlargement, significant ventricular dysfunction, congestive heart failure, rapid ventricular response, or complex ventricular ectopy may be poorer candidates for quinidine and may need a different approach.

Quinidine gluconate is not a routine at-home medication. It is generally used as part of a hospital-based, monitored antiarrhythmic protocol, especially when your vet wants IV access and rapid dose adjustment. In practice, your vet may use quinidine gluconate early in a protocol or in selected cases where close ECG monitoring, blood pressure support, and emergency intervention are immediately available.

Quinidine dosing in horses is highly individualized and should never be estimated at home. Published veterinary references list quinidine gluconate at 1 to 1.5 mg/kg IV every 5 to 10 minutes in horses, while oral quinidine sulfate protocols commonly use 22 mg/kg by mouth or by nasogastric tube every 2 hours initially under continuous monitoring. Your vet chooses the protocol based on the horse's ECG, body weight, response, and risk factors.

For horses being treated for atrial fibrillation, monitoring is a major part of dosing. Your vet may place an IV catheter before treatment, run a continuous ECG, and track heart rate, QRS widening, rhythm changes, blood pressure, and sometimes plasma quinidine concentrations. AAEP cardiology guidance notes that therapeutic plasma quinidine concentrations are often targeted around 2 to 5 mcg/mL, and treatment intervals may be lengthened if concentrations rise or if adverse effects appear.

This is not a medication to continue if a horse seems uncomfortable or develops new signs. If diarrhea, nasal swelling, weakness, worsening arrhythmias, collapse, or signs of laminitis appear, treatment may need to be stopped right away. Because quinidine can become toxic as blood levels rise, even a protocol that starts appropriately can become unsafe without repeated reassessment by your vet.

See your vet immediately if your horse develops weakness, collapse, severe depression, marked tachycardia, worsening irregular rhythm, trouble breathing, or signs of laminitis while receiving quinidine. These can signal serious toxicity or a dangerous change in heart function.

Commonly discussed adverse effects of quinidine in horses include gastrointestinal upset, especially diarrhea, along with nasal mucosal swelling and urticarial wheals. Some horses also show restlessness, reduced appetite, or a generally unwell appearance during treatment. These signs matter because they may be the first clue that the horse is not tolerating the drug well.

More serious risks include hypotension, conduction disturbances, proarrhythmia, and worsening heart failure due to quinidine's negative inotropic effects. In plain terms, the drug can sometimes make the rhythm problem worse or reduce the heart's pumping efficiency. Laminitis is also a recognized adverse effect in horses receiving quinidine, which is one reason these cases are managed so carefully in a hospital setting.

Quinidine can interact with other medications that affect heart rhythm, heart rate, blood pressure, or cardiac contractility. That includes other antiarrhythmics and drugs that may slow conduction or increase the risk of dangerous rhythm changes. Your vet should know about every prescription, supplement, electrolyte product, and performance medication your horse has received recently.

Particular caution is warranted if a horse is also receiving digoxin, because quinidine can increase digoxin exposure and raise the risk of toxicity. Combining quinidine with other antiarrhythmics may also increase the chance of conduction abnormalities or proarrhythmia unless your vet is intentionally using a specialist-guided protocol.

Electrolyte status matters too. Low potassium or magnesium can make arrhythmia management harder and may change how safely antiarrhythmic drugs work. That is why your vet may recommend bloodwork before and during treatment, especially in racehorses, endurance horses, or horses with dehydration, diarrhea, or recent diuretic use.